- Duo Discover
- Posts
- AI Can Recommend If You Need to Be Screened for Cancer
AI Can Recommend If You Need to Be Screened for Cancer
You’ve heard the hype. It’s time for results.
After two years of siloed experiments, proofs of concept that fail to scale, and disappointing ROI, most enterprises are stuck. AI isn't transforming their organizations — it’s adding complexity, friction, and frustration.
But Writer customers are seeing positive impact across their companies. Our end-to-end approach is delivering adoption and ROI at scale. Now, we’re applying that same platform and technology to build agentic AI that actually works for every enterprise.
This isn’t just another hype train that overpromises and underdelivers. It’s the AI you’ve been waiting for — and it’s going to change the way enterprises operate. Be among the first to see end-to-end agentic AI in action. Join us for a live product release on April 10 at 2pm ET (11am PT).
Can't make it live? No worries — register anyway and we'll send you the recording!
US researchers suggest that Artificial Intelligence (AI) can offer a more accurate and personalized approach to cancer screening than current age-based methods. Their research proposes a shift in how the healthcare system assesses cancer risk.
The Current Problem with Age-Based Screening
In most countries—including the United States—cancer screening is recommended based primarily on a person's age.
Breast Cancer: Women are typically advised to begin screening at age 40 or 50.
Colon Cancer: Screenings often begin at age 45.
➤ Flaws in the Age-Based Approach:
May miss younger individuals who are at high risk.
May lead to unnecessary tests for older adults who have a low risk.
The Role of AI in Risk Assessment
✅ What AI Brings to the Table:
Evaluates a person’s entire medical history, social background, and other individual-level data.
Helps identify real, personalized risk—regardless of age.
🧠 Who’s Behind This?
Lead Researcher: Prof. Farrokh Alemi, George Mason University
Published In: Quality Management in Health Care (Special Issue)
Team Contribution: Authored five research papers on AI-powered cancer risk models.
Key Findings of the Research
The team found that AI can predict the likelihood of various cancers with impressive accuracy:
Type of Cancer | AI Accuracy Rate |
---|---|
Skin Cancer | ~90% |
Malignant Brain Tumors | ~80% |
Kidney Cancer | ~80% |
Breast Cancer Relapse | ~70% |
Liver Cancer | ~60% |
Why This Matters
These AI-powered models can assist doctors in making smarter decisions about who should be screened:
Early Detection: Cancers can be found at a more treatable stage.
Cost Efficiency: Reduces the financial burden of unnecessary screenings.
Fair Access: Risk-based models are non-invasive, affordable, and applicable across demographics.
Quotes from the Researchers
“AI systems can easily reach people online and help them find out if they are at risk,” said Prof. Alemi.
“People at high risk can talk to their doctor about getting screened. Those at low risk can avoid unnecessary tests.”
He called this a major advancement in predictive medicine—a healthcare model focused on preventing disease before it occurs.
“These risk-based models are non-invasive, more accurate, cost-effective, and work for everyone,” he added.
Another researcher on the team, Yili Lin, said:
“Using these models in everyday clinical settings could improve healthcare quality and allow earlier detection, which increases survival chances.”
Current Limitations and the Call to Action
Despite the strong data supporting AI’s capabilities:
These models are not yet part of official screening guidelines from the US Preventive Services Task Force (USPSTF).
The research team urges health systems to move beyond outdated age-based protocols and integrate data-driven tools.
Conclusion
This new approach presents a transformative opportunity in healthcare—shifting from one-size-fits-all screening to smart, personalized, AI-driven diagnostics. The researchers advocate for a future where technology plays a central role in cancer prevention, potentially saving lives and reducing healthcare costs.
What did you think of this week's issue?We take your feedback seriously. |